Allovir logo

Allovir Share Price Today

(NASDAQ: ALVR)

Allovir share price is $9.77 & ₹850.63 as on 6 Mar 2025, 2.30 'hrs' IST

$9.77

-0.02

(-0.2%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Allovir share price in Dollar and Rupees. Guide to invest in Allovir stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Allovir, along with analyst recommendations, forecasts, and comprehensive financials.

Allovir share price movements

  • Today's Low: $9.63
    Today's High: $10.15

    Day's Volatility :5.12%

  • 52 Weeks Low: $7.96
    52 Weeks High: $24.15

    52 Weeks Volatility :67.04%

Allovir (ALVR) Returns

PeriodAllovir IncSector (Health Care)Index (Russel 2000)
3 Months
-14.87%
3.7%
0.0%
6 Months
-44.21%
-2.8%
0.0%
1 Year
-42.0%
2.5%
0.0%
3 Years
-94.28%
12.9%
-11.6%

Allovir (ALVR) Key Statistics

in dollars & INR

Previous Close
$9.79
Open
$9.63
Today's High
$10.15
Today's Low
$9.63
Market Capitalization
$85.3M
Today's Volume
$3.6K
52 Week High
$24.15
52 Week Low
$7.96
Revenue TTM
$0.0
EBITDA
$-120.5M
Earnings Per Share (EPS)
$-0.9
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-80.33%

How to invest in Allovir Stock (ALVR) from India?

It is very easy for Indian residents to invest directly in Allovir from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Allovir stock in both Indian Rupees (INR) and US Dollars (USD). Search for Allovir or ALVR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Allovir or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Allovir shares which would translate to 0.089 fractional shares of Allovir as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Allovir, in just a few clicks!

Returns in Allovir (ALVR) for Indian investors in Rupees

The Allovir stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Allovir investment value today

Current value as on today

₹63,047

Returns

₹36,953

(-36.95%)

Returns from Allovir Stock

₹42,018 (-42.02%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Allovir (ALVR)

-21%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Allovir Stock from India on INDmoney has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Allovir

  • EcoR1 Capital, LLC

    9.74%

  • Octagon Capital Advisors LP

    9.67%

  • Siren, L.L.C.

    5.69%

  • Millennium Management LLC

    2.83%

  • Redmile Group, LLC

    1.65%

  • Renaissance Technologies Corp

    0.67%

Analyst Recommendation on Allovir

Sell

    0%Buy

    40%Hold

    60%Sell

Based on 10 Wall street analysts offering stock ratings for Allovir(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
4
4
4
Sell
6
6
6

Analyst Forecast on Allovir Stock (ALVR)

What analysts predicted

Downside of 87.72%

Target:

$1.20

Current:

$9.77

Insights on Allovir Stock (Ticker Symbol: ALVR)

  • Price Movement

    In the last 6 months, ALVR stock has moved down by -44.4%
  • ALVR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 108.5%
  • ALVR vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 145.8%

Allovir Technicals Summary

Sell

Neutral

Buy

Allovir is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Allovir (ALVR) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Allovir Inc logo
-2.88%
-44.21%
-42.0%
-94.28%
-98.33%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Allovir Inc logo
NA
NA
NA
-0.42
-0.8
-0.37
NA
1.06
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Allovir Inc logo
Sell
$85.3M
-98.33%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Allovir

Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Its preclinical and clinical development product candidates include ALVR106 for the respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109 to treat SARS-CoV-2 and COVID-19; ALVR107 for treating hepatitis B; and ALVR108. The company was formerly known as ViraCyte, Inc. and changed its name to Allovir, Inc. in May 2019. The company was incorporated in 2013 and is based in Waltham, Massachusetts.
Organization
Allovir
Employees
8
CEO
Mr. Vikas Sinha C.A., CPA, M.B.A.
Industry
Health Technology

Management People of Allovir

NameTitle
Mr. David L. Hallal
Executive Chairman of the Board
Mr. Vikas Sinha C.A., CPA, M.B.A.
CEO & Director
Mr. Edward Miller J.D.
General Counsel & Secretary
Mr. Brett R. Hagen
Chief Accounting Officer
Dr. Ann M. Leen Ph.D.
Chief Scientific Officer

Important FAQs about investing in ALVR Stock from India :

What is Allovir share price today?

Allovir share price today stands at $9.77, Open: $9.63 ; Previous Close: $9.79 ; High: $10.15 ; Low: $9.63 ; 52 Week High: $24.15 ; 52 Week Low: $7.96.

The stock opens at $9.63, after a previous close of $9.79. The stock reached a daily high of $10.15 and a low of $9.63, with a 52-week high of $24.15 and a 52-week low of $7.96.

Can Indians buy Allovir shares?

Yes, Indians can invest in the Allovir (ALVR) from India.

With INDmoney, you can buy Allovir at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Allovir at zero transaction cost.

How can I buy Allovir shares from India?

It is very easy to buy Allovir from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Allovir (ALVR) be purchased?

Yes, you can buy fractional shares of Allovir with INDmoney app.

What are the documents required to start investing in Allovir stocks?

To start investing in Allovir, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Allovir Stock (ALVR)?

Today’s highest price of Allovir (ALVR) is $10.15.

Today’s lowest price of Allovir (ALVR) is $9.63.

What is today's market capitalisation of Allovir?

Today's market capitalisation of Allovir ALVR is 85.3M

What is the 52 Week High and Low Range of Allovir Stock (ALVR)?

  • 52 Week High

    $24.15

  • 52 Week Low

    $7.96

What are the historical returns of Allovir (ALVR)?

  • 1 Month Returns

    -2.88%

  • 3 Months Returns

    -44.21%

  • 1 Year Returns

    -42%

  • 5 Years Returns

    -98.33%

Who is the Chief Executive Officer (CEO) of Allovir ?

Mr. Vikas Sinha C.A., CPA, M.B.A. is the current Chief Executive Officer (CEO) of Allovir.